Trulicity and Bydureon: two new injectables for type 2 diabetesFirst once-weekly glucagon-like peptide-1 receptor agonists reach the Canadian market. Basaglar: first subsequent entry biologic for insulin glargineApproved for use in adults and children older than six years. Johnson & Johnson, ViaCyte testing possible diabetes cure Companies co-developing first stem cell treatment for the disease. EXCLUSIVE VIDEO: Insulin for type 2 diabetes Diabetes: We need to do better, says CIHI report Canada has one of the highest prevalence rates among developed countries Humalog KwikPen 200 units/mL: new higher-strength pen now available More concentrated product for patients who need more than 20 units of rapid-acting insulin per day. Tools for your diabetes patients that will help you in your practice A guide to the Canadian Diabetes Association's online resources Dietary strategies for prediabetes and early type 2 disease Type 2 diabetes: The new drugs in town What you need to know about sodium- glucose linked transporter 2 inhibitors Machine developed by Winnipeg company screens for Type 2 diabetes Manufacturer hopes device will soon be in pharmacies across the country. First Previous 30 31 32 33 34 Next Last
